Cargando…

Influence of Ingestion of Eicosapentaenoic Acid-Rich Fish Oil on Oxidative Stress at the Menstrual Phase: A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Trial

BACKGROUND: This study examines the effect of the supplements on the redox reaction in menstrual cycle. Participants took eicosapentaenoic acid (EPA)-rich fish oil supplements over two menstrual cycles. MATERIALS AND METHODS: For this randomized, double-blind, placebo-controlled trial, 21 female mem...

Descripción completa

Detalles Bibliográficos
Autores principales: Mano, Yoshihiko, Kato, Ayaka, Fukuda, Nobuo, Yamada, Keiko, Yanagimoto, Kenichi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Mary Ann Liebert, Inc., publishers 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9380882/
https://www.ncbi.nlm.nih.gov/pubmed/35982775
http://dx.doi.org/10.1089/whr.2022.0003
_version_ 1784768960858685440
author Mano, Yoshihiko
Kato, Ayaka
Fukuda, Nobuo
Yamada, Keiko
Yanagimoto, Kenichi
author_facet Mano, Yoshihiko
Kato, Ayaka
Fukuda, Nobuo
Yamada, Keiko
Yanagimoto, Kenichi
author_sort Mano, Yoshihiko
collection PubMed
description BACKGROUND: This study examines the effect of the supplements on the redox reaction in menstrual cycle. Participants took eicosapentaenoic acid (EPA)-rich fish oil supplements over two menstrual cycles. MATERIALS AND METHODS: For this randomized, double-blind, placebo-controlled trial, 21 female members of a university basketball team were selected. Participants were allocated into the EPA/docosahexaenoic acid (DHA) group (EG, n = 11) and control group (CG, n = 10) through stratified randomization. The EG and CG took 3600 mg fish oil (containing 900 mg EPA and 403 mg DHA) and 3600 mg corn oil (without EPA and DHA), respectively, every day for two menstrual cycles. The redox reaction was measured four times: the menstrual and follicular phases in two menstrual cycles. RESULTS: There was a significant difference in reactive oxygen metabolites (d-ROMs) and potential antioxidant capacity during the menstrual phase by the main effect of time (before and after intake) in EG and CG (p < 0.01). In a subsequent test, d-ROMs were significantly lower after intake in EG and CG (p < 0.05); however, no significant difference in potential antioxidant capacity was found. A significant difference was noted in d-ROMs and potential antioxidant capacity during the follicular phase by the effect of time (before and after intake) only in EG (p < 0.01). Significant decreases in d-ROMs and increases in potential antioxidant capacities were observed after intake (p < 0.05). CONCLUSION: EPA-rich fish oil supplementation over two menstrual cycles demonstrated active involvement in the antioxidant function during menstrual and follicular phases. The protocol was registered at the University Hospital Medical Information Network Clinical Trial Registry (registration no. UMIN000028795).
format Online
Article
Text
id pubmed-9380882
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Mary Ann Liebert, Inc., publishers
record_format MEDLINE/PubMed
spelling pubmed-93808822022-08-17 Influence of Ingestion of Eicosapentaenoic Acid-Rich Fish Oil on Oxidative Stress at the Menstrual Phase: A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Trial Mano, Yoshihiko Kato, Ayaka Fukuda, Nobuo Yamada, Keiko Yanagimoto, Kenichi Womens Health Rep (New Rochelle) Original Article BACKGROUND: This study examines the effect of the supplements on the redox reaction in menstrual cycle. Participants took eicosapentaenoic acid (EPA)-rich fish oil supplements over two menstrual cycles. MATERIALS AND METHODS: For this randomized, double-blind, placebo-controlled trial, 21 female members of a university basketball team were selected. Participants were allocated into the EPA/docosahexaenoic acid (DHA) group (EG, n = 11) and control group (CG, n = 10) through stratified randomization. The EG and CG took 3600 mg fish oil (containing 900 mg EPA and 403 mg DHA) and 3600 mg corn oil (without EPA and DHA), respectively, every day for two menstrual cycles. The redox reaction was measured four times: the menstrual and follicular phases in two menstrual cycles. RESULTS: There was a significant difference in reactive oxygen metabolites (d-ROMs) and potential antioxidant capacity during the menstrual phase by the main effect of time (before and after intake) in EG and CG (p < 0.01). In a subsequent test, d-ROMs were significantly lower after intake in EG and CG (p < 0.05); however, no significant difference in potential antioxidant capacity was found. A significant difference was noted in d-ROMs and potential antioxidant capacity during the follicular phase by the effect of time (before and after intake) only in EG (p < 0.01). Significant decreases in d-ROMs and increases in potential antioxidant capacities were observed after intake (p < 0.05). CONCLUSION: EPA-rich fish oil supplementation over two menstrual cycles demonstrated active involvement in the antioxidant function during menstrual and follicular phases. The protocol was registered at the University Hospital Medical Information Network Clinical Trial Registry (registration no. UMIN000028795). Mary Ann Liebert, Inc., publishers 2022-07-13 /pmc/articles/PMC9380882/ /pubmed/35982775 http://dx.doi.org/10.1089/whr.2022.0003 Text en © Yoshihiko Mano et al., 2022; Published by Mary Ann Liebert, Inc. https://creativecommons.org/licenses/by/4.0/This Open Access article is distributed under the terms of the Creative Commons License [CC-BY] (http://creativecommons.org/licenses/by/4.0 (https://creativecommons.org/licenses/by/4.0/) ), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Original Article
Mano, Yoshihiko
Kato, Ayaka
Fukuda, Nobuo
Yamada, Keiko
Yanagimoto, Kenichi
Influence of Ingestion of Eicosapentaenoic Acid-Rich Fish Oil on Oxidative Stress at the Menstrual Phase: A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Trial
title Influence of Ingestion of Eicosapentaenoic Acid-Rich Fish Oil on Oxidative Stress at the Menstrual Phase: A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Trial
title_full Influence of Ingestion of Eicosapentaenoic Acid-Rich Fish Oil on Oxidative Stress at the Menstrual Phase: A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Trial
title_fullStr Influence of Ingestion of Eicosapentaenoic Acid-Rich Fish Oil on Oxidative Stress at the Menstrual Phase: A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Trial
title_full_unstemmed Influence of Ingestion of Eicosapentaenoic Acid-Rich Fish Oil on Oxidative Stress at the Menstrual Phase: A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Trial
title_short Influence of Ingestion of Eicosapentaenoic Acid-Rich Fish Oil on Oxidative Stress at the Menstrual Phase: A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Trial
title_sort influence of ingestion of eicosapentaenoic acid-rich fish oil on oxidative stress at the menstrual phase: a randomized, double-blind, placebo-controlled, parallel-group trial
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9380882/
https://www.ncbi.nlm.nih.gov/pubmed/35982775
http://dx.doi.org/10.1089/whr.2022.0003
work_keys_str_mv AT manoyoshihiko influenceofingestionofeicosapentaenoicacidrichfishoilonoxidativestressatthemenstrualphasearandomizeddoubleblindplacebocontrolledparallelgrouptrial
AT katoayaka influenceofingestionofeicosapentaenoicacidrichfishoilonoxidativestressatthemenstrualphasearandomizeddoubleblindplacebocontrolledparallelgrouptrial
AT fukudanobuo influenceofingestionofeicosapentaenoicacidrichfishoilonoxidativestressatthemenstrualphasearandomizeddoubleblindplacebocontrolledparallelgrouptrial
AT yamadakeiko influenceofingestionofeicosapentaenoicacidrichfishoilonoxidativestressatthemenstrualphasearandomizeddoubleblindplacebocontrolledparallelgrouptrial
AT yanagimotokenichi influenceofingestionofeicosapentaenoicacidrichfishoilonoxidativestressatthemenstrualphasearandomizeddoubleblindplacebocontrolledparallelgrouptrial